The popularity of Viagra initially drove a boom for major pharmaceutical companies, but recent changes present a murky outlook for shareholders. Generic competitors are eating into revenue, and ongoing litigation add https://fanniehrpv710126.designi1.com/61881146/the-blue-pill-and-the-pharmaceutical-industry-a-risky-bet